A Phase 1, Dose-Escalation/Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Orally Administered CB-5083 in Subjects with Lymphoid Hematological Malignancies
Administered By
Awarded By
Contributors
- Jaffe, Glenn Jay Principal Investigator
Start/End
- June 27, 2016 - May 9, 2018